A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses
- 11 January 2008
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 61 (1) , 40-48
- https://doi.org/10.1016/j.diagmicrobio.2007.12.002
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim Fonds
This publication has 44 references indexed in Scilit:
- Naturally Occurring Anti- Escherichia coli Protein Antibodies in the Sera of Healthy Humans Cause Analytical Interference in a Recombinant Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Severe Acute Respiratory SyndromeClinical and Vaccine Immunology, 2007
- Comparative Analysis of 22 Coronavirus HKU1 Genomes Reveals a Novel Genotype and Evidence of Natural Recombination in Coronavirus HKU1Journal of Virology, 2006
- Coronavirus HKU1 and Other Coronavirus Infections in Hong KongJournal of Clinical Microbiology, 2006
- Coronavirus HKU1 Infection in the United StatesEmerging Infectious Diseases, 2006
- Croup Is Associated with the Novel Coronavirus NL63PLoS Medicine, 2005
- Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serumEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Retrospective Serological Investigation of Severe Acute Respiratory Syndrome Coronavirus Antibodies in Recruits from Mainland ChinaClinical and Vaccine Immunology, 2005
- Identification of a new human coronavirusNature Medicine, 2004
- Profiles of Antibody Responses against Severe AcuteRespiratory Syndrome Coronavirus Recombinant Proteins andTheir Potential Use as DiagnosticMarkersClinical and Vaccine Immunology, 2004
- Recombinant Protein-Based Enzyme-Linked Immunosorbent Assay and Immunochromatographic Tests for Detection of Immunoglobulin G Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus in SARS PatientsClinical and Vaccine Immunology, 2004